Serum macrophage migration inhibitory factor reflects adrenal function in the hypothalamo-pituitary-adrenal axis of septic patients: An observational study

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Miyauchi, Takashi ^a   Tsuruta, Ryoske ^a   Fujita, Motoki ^a   Kaneko, Tadashi ^a   Kasaoka, Shunji ^a   Maekawa, Tsuyoshi ^a  

^a YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOCORTICOID; HYDROCORTISONE; MACROPHAGE MIGRATION INHIBITION FACTOR; CORTICOTROPIN;

ADRENAL FUNCTION; ADRENAL INSUFFICIENCY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CORTICOTROPIN TEST; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFLAMMATION; INTENSIVE CARE UNIT; MALE; OBSERVATIONAL STUDY; PROTHROMBIN TIME; RECEIVER OPERATING CHARACTERISTIC; SEPSIS; BLOOD; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADRENAL INSUFFICIENCY; ADRENOCORTICOTROPIC HORMONE; AGED; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTENSIVE CARE UNITS; MACROPHAGE MIGRATION-INHIBITORY FACTORS; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; ROC CURVE;

EID: 74549224073     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-209     Document Type: Article

References (34)

1. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345:1368-1377. 10.1056/NEJMoa010307, 11794169.
2. Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 2001, 345:1359-1367. 10.1056/NEJMoa011300, 11794168.
3. Vincent JL, Bernard GR, Beale R, Doig C, Putensen C, Dhainaut JF, Artigas A, Fumagalli R, Macias W, Wright T, Wong K, Sundin DP, Turlo MA, Janes J. Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment. Crit Care Med 2005, 33:2266-2277. 10.1097/01.CCM.0000181729.46010.83, 16215381.
4. Lauzier F, Lévy B, Lamarre P, Lesur O. Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial. Intensive Care Med 2006, 32:1782-1789. 10.1007/s00134-006-0378-0, 17019548.
5. Vinsonneau C, Camus C, Combes A, Costa de Beauregard MA, Klouche K, Pallot JL, Chiche JD, Taupin P, Landais P, Dhainaut JF. Continuous venovenous haemodiafiltration versus intermittent haemodialysis for acute renal failure in patients with multiple-organ dysfunction syndrome: a multicentre randomised trial. Lancet 2006, 368:379-385. 10.1016/S0140-6736(06)69111-3, 16876666.
6. Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887. 10.1056/NEJMoa067373, 18305265.
7. Cruz DN, Antonelli M, Fumagalli R, Foltran F, Brienza N, Donati A, Malcangi V, Petrini F, Volta G, Pallavicini FMB, Rottoli F, Giunta F, Ronco C. Early use of polymyxin B hemoperfusion in abdominal septic shock. JAMA 2009, 301:2445-2452. 10.1001/jama.2009.856, 19531784.
8. Annane D, Sébille V, Troché G, Raphaël JC, Gajdos P. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA 2000, 283:1038-1045. 10.1001/jama.283.8.1038, 10697064.
9. Gonzalez H, Nardi O, Annane D. Relative adrenal failure in the ICU: An identifiable problem requiring treatment. Crit Care Clin 2006, 22:105-118. 10.1016/j.ccc.2005.09.001, 16399022.
10. Keh D, Boehnke T, Weber-Cartens S, Schulz C, Ahlers O, Bercker S, Volk HD, Doecke WD, Falke KJ, Gerlach H. Immunologic and hemodynamic effects of "low-dose" hydrocortisone in septic shock. Am J Respir Crit Care Med 2003, 167:512-520. 10.1164/rccm.200205-446OC, 12426230.
11. Confalonieri M, Urbino R, Potena A, Piattella M, Parigi P, Puccio G, Porta RD, Giorgio C, Blasi F, Umberger R, Meduri GU. Hydrocortisone infusion for severe community-acquired pneumonia. Am J Respir Crit Care Med 2005, 171:242-248. 10.1164/rccm.200406-808OC, 15557131.
12. Lefering R, Neugebauer EA. Steroid controversy in sepsis and septic shock: a meta-analysis. Crit Care Med 1995, 23:1294-1303. 10.1097/00003246-199507000-00021, 7600840.
13. Zeni F, Freeman B, Natanson C. Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment. Crit Care Med 1997, 25:1095-1100. 10.1097/00003246-199707000-00001, 9233726.
14. Bloom B, Bennett B. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 1966, 153:80-82. 10.1126/science.153.3731.80, 5938421.
15. Calandra T, Bernhagen J, Mitchell RA, Bucala R. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 1994, 179:1895-1902. 10.1084/jem.179.6.1895, 2191507, 8195715.
16. Nishihira J, Koyama Y, Mizue Y. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 1998, 10:199-205. 10.1006/cyto.1997.0276, 9576065.
17. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R. MIF is a pituitary-derived cytokine that potentiates lethal endotoxemia. Nature 1993, 365:756-759. 10.1038/365756a0, 8413654.
18. Calandra T, Bernhagen J, Metz CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 1995, 377:68-71. 10.1038/377068a0, 7659164.
19. The ACCP/SCCM Consensus Conference Committee Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101:1644-1655. 10.1378/chest.101.6.1644, 1303622, The ACCP/SCCM Consensus Conference Committee.
20. Annane D, Sébille V, Charpentier C, Bollaert PE, François B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troché G, Chaumet-Riffaud P, Bellissant E. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002, 288:862-871. 10.1001/jama.288.7.862, 12186604.
21. Annane D, Maxime V, Ibrahim F, Alvarez JC, Abe E, Boudou P. Diagnosis of adrenal insufficiency in severe sepsis and septic shock. Am J Respir Crit Care Med 2006, 174:1319-1326. 10.1164/rccm.200509-1369OC, 16973979.
22. Marik PE, Pastores SM, Annane D, Meduri GU, Sprung CL, Arlt W, Keh D, Briegel J, Beishuizen A, Dimopoulou I, Tsagarakis S, Singer M, Chrousos GP, Zaloga G, Bokhari F, Vogeser M, . American College of Critical Care Medicine Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: Consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008, 36:1937-1949. 10.1097/CCM.0b013e31817603ba, 18496365, American College of Critical Care Medicine.
23. Beishuizen A, Thijs LG, Haanen C, Vermes I. Macrophage migration inhibitory factor and hypothalamo-pituitary-adrenal function during critical illness. J Clin Endocrinol Metab 2001, 86:2811-2816. 10.1210/jc.86.6.2811, 11397892.
24. Bozza FA, Gomes RN, Japiassú AM, Soares M, Castro-Faria-Neto HC, Bozza PT, Bozza MT. Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock 2004, 22:309-313. 10.1097/01.shk.0000140305.01641.c8, 15377884.
25. Sprong T, Pickkers P, Geurts-Moespot A, Ven-Jongekrijg J, Neeleman C, Knaup M, LeRoy D, Calandra T, van der Meer JW, Sweep F, van Deuren M. Macrophage migration inhibitory factor (MIF) in meningococcal septic shock and experimental human endotoxemia. Shock. 2004, 27(5):482-487. 10.1097/01.shk.0000140305.01641.c8, 15377884.
26. Emonts M, Sweep FC, Grebenchtchikov N, Geurts-Moespot A, Knaup M, Chanson AL, Erard V, Renner P, Hermans PW, Hazelzet JA, Calandra T. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clin Infect Dis 2007, 44:1321-1328. 10.1086/514344, 17443469.
27. Maxime V, Fitting C, Annane D, Cavaillon JM. Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock. J Infect Dis 2005, 191:138-144. 10.1086/426401, 15593015.
28. Ho JT, Al-Musalhi H, Chapman MJ, Quach T, Thomas PD, Baqley CJ, Lewis JG, Torpy DJ. Septic shock and sepsis: A comparison of total and free plasma cortisol levels. J Clin Endocrinol Metab 2006, 91:105-114. 10.1210/jc.2005-0265, 16263835.
29. De Jong MF, Beishuizen A, Spijkstra JJ, Girbes AR, Strack van Schijndel RJ, Twisk JW, Groeneveld AB. Predicting a low cortisol response to adrenocorticotropic hormone in the critically ill: a retrospective cohort study. Crit Care 2007, 11:R61. 10.1186/cc5928, 2206419, 17524133.
30. De Jong MF, Beishuizen A, Spijkstra JJ, Groeneveld AB. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock. Crit Care Med 2007, 35:1896-1903. 10.1097/01.CCM.0000275387.51629.ED, 17568326.
31. Widmer IE, Puder JJ, König C, Pargger H, Zerkowski HR, Girard J, Müller B. Cortisol response in relation to the severity of stress and illness. J Clin Endocrinol Metab 2005, 90:4579-4586. 10.1210/jc.2005-0354, 15886236.
32. Makita H, Nishimura M, Miyamoto K, Nakano T, Tanino Y, Hirokawa J, Nishihira J, Kawakami Y. Effect of anti-macrophage migration inhibitory factor antibody on lipopolysaccharide-induced pulmonary neutrophil accumulation. Am J Respir Crit Care Med 1998, 158:573-579.
33. Gando S, Sawamura A, Hayakawa M, Hoshino H, Kubota N, Nishihira J. High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation. Inflammation 2007, 30:118-124. 10.1007/s10753-007-9027-1, 17534704.
34. Vogeser M, Mohnle P, Briegel J. Free serum cortisol: Quantification applying equilibrium dialysis or ultrafiltration and an automated immunoassay system. Clin Chem Lab Med 2007, 45:521-525. 10.1515/CCLM.2007.104, 17439331.